Skip to main content
. 2017 Nov 15;12(11):e0187857. doi: 10.1371/journal.pone.0187857

Fig 5. Sofosbuvir and PLA2-CB combined treatment.

Fig 5

Huh-7.5 cells stably harboring the SGR-Feo-JFH-1 were seeded into 96-well plates and treated with PLA2-CB, Sofosbuvir or the combination PLA2-CB and Sofosbuvir for 48 h. After the treatment replication level (A) and cell viability (B) were measured. P < 0.001 was considered significant (*).